After a data integrity probe and an ensuing legal saga, a judge ruled that Fresenius legally abandoned its $4.3 billion Akorn buyout.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,